A long‐lived Aβ oligomer resistant to fibrillization
- Department of Pharmaceutical Chemistry University of California San Francisco California
- Institute for Neurodegenerative Diseases and Department of Neurology Weill Institute for Neurosciences, University of California San Francisco California, Department of Biochemistry and Biophysics University of California San Francisco California
- Institute for Neurodegenerative Diseases and Department of Neurology Weill Institute for Neurosciences, University of California San Francisco California
Abstract
The hydrophobic Aβ peptide is highly aggregation prone; it first forms soluble oligomers, which then convert into the amyloid fibrils found in the cerebral plaques of Alzheimer's disease. It is generally understood that as the peptide concentration of Aβ increases, the fibrillization process is accelerated, but we examine the limits on this phenomenon. We found that once a threshold concentration of Aβ is exceeded, a stable oligomer is formed at the expense of fibril formation. The suppression of fibril formation was observed by amyloid‐binding dye Thioflavin T and solution nuclear magnetic resonance (NMR). Small‐angle X‐ray scattering, size exclusion chromatography, and analytical ultracentrifugation demonstrated that Aβ peptides form a range of compact species, with a dimer being an early highly populated oligomer. Solution NMR allowed us to define the secondary structure of this Aβ dimer, which shows interlocking contacts between C‐terminal peptide strands. Thus, we present a novel Aβ oligomer that resists conversion to fibrils and remains stable for more than one year.
- Sponsoring Organization:
- USDOE
- Grant/Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1416592
- Journal Information:
- Biopolymers, Journal Name: Biopolymers Journal Issue: 8 Vol. 109; ISSN 0006-3525
- Publisher:
- Wiley Blackwell (John Wiley & Sons)Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Atomic-resolution structure of a disease-relevant Aβ(1–42) amyloid fibril
Design of non-aggregating variants of Aβ peptide